B2B2C or direct to consumer: Which telemedicine model will win?

Rob Coppedge, Cambia senior vice president of strategic investment and corporate development, shares his perspective on the telemedicine market.

Click here to read "B2B2C or direct to consumer: Which telemedicine model will win?" by MedCity News.